New inhaler aims to ease breathing for COPD patients
NCT ID NCT07140328
First seen Apr 09, 2026 · Last updated May 22, 2026 · Updated 8 times
Summary
This study tests a new medicine called HSK39004, given as an inhaler, for people with chronic obstructive pulmonary disease (COPD). About 50 adults aged 40 to 80 with COPD will receive either the new inhaler or a placebo. The main goal is to see if the drug improves lung function over 4 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE (COLD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Jiangsu Provincial People's Hospital
Nanchang, Jiangsu, China
Conditions
Explore the condition pages connected to this study.